These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 25414004)

  • 21. Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis.
    Sastre-Garriga J; Arévalo MJ; Renom M; Alonso J; González I; Galán I; Montalban X; Rovira A
    J Neurol Sci; 2009 Jul; 282(1-2):120-4. PubMed ID: 19157420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regional but not global brain damage contributes to fatigue in multiple sclerosis.
    Rocca MA; Parisi L; Pagani E; Copetti M; Rodegher M; Colombo B; Comi G; Falini A; Filippi M
    Radiology; 2014 Nov; 273(2):511-20. PubMed ID: 24927473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain atrophy and physical disability in primary progressive multiple sclerosis: A volumetric study.
    Galego O; Gouveia A; Batista S; Moura C; Machado E
    Neuroradiol J; 2015 Jun; 28(3):354-8. PubMed ID: 26246109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive reserve, cognition, and regional brain damage in MS: A 2 -year longitudinal study.
    Rocca MA; Riccitelli GC; Meani A; Pagani E; Del Sette P; Martinelli V; Comi G; Falini A; Filippi M
    Mult Scler; 2019 Mar; 25(3):372-381. PubMed ID: 29303036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subcortical deep gray matter pathology in patients with multiple sclerosis is associated with white matter lesion burden and atrophy but not with cortical atrophy: a diffusion tensor MRI study.
    Cappellani R; Bergsland N; Weinstock-Guttman B; Kennedy C; Carl E; Ramasamy DP; Hagemeier J; Dwyer MG; Patti F; Zivadinov R
    AJNR Am J Neuroradiol; 2014 May; 35(5):912-9. PubMed ID: 24335548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural MRI substrates of cognitive impairment in neuromyelitis optica.
    Liu Y; Fu Y; Schoonheim MM; Zhang N; Fan M; Su L; Shen Y; Yan Y; Yang L; Wang Q; Zhang N; Yu C; Barkhof F; Shi FD
    Neurology; 2015 Oct; 85(17):1491-9. PubMed ID: 26423432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Gray matter lesions and cognitive impairment in multiple sclerosis].
    Kawachi I; Saji E; Nishizawa M
    Rinsho Shinkeigaku; 2014; 54(12):1060-2. PubMed ID: 25672709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of regional gray matter and white matter atrophy in cortical multiple sclerosis.
    Parisi L; Rocca MA; Mattioli F; Riccitelli GC; Capra R; Stampatori C; Bellomi F; Filippi M
    J Neurol; 2014 Sep; 261(9):1715-25. PubMed ID: 24952616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosis.
    Abdel-Aziz K; Schneider T; Solanky BS; Yiannakas MC; Altmann DR; Wheeler-Kingshott CA; Peters AL; Day BL; Thompson AJ; Ciccarelli O
    Brain; 2015 Jun; 138(Pt 6):1568-82. PubMed ID: 25863355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hereditary diffuse leukoencephalopathy with spheroids - a volumetric and radiological comparison with multiple sclerosis patients and healthy controls.
    Granberg T; Hashim F; Andersen O; Sundal C; Karrenbauer VD
    Eur J Neurol; 2016 Apr; 23(4):817-22. PubMed ID: 26756564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gray matter atrophy cannot be fully explained by white matter damage in patients with MS.
    Zhang J; Giorgio A; Vinciguerra C; Stromillo ML; Battaglini M; Mortilla M; Tappa Brocci R; Portaccio E; Amato MP; De Stefano N
    Mult Scler; 2021 Jan; 27(1):39-51. PubMed ID: 31976807
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuro-cognitive mechanisms of simultanagnosia in patients with posterior cortical atrophy.
    Neitzel J; Ortner M; Haupt M; Redel P; Grimmer T; Yakushev I; Drzezga A; Bublak P; Preul C; Sorg C; Finke K
    Brain; 2016 Dec; 139(Pt 12):3267-3280. PubMed ID: 27702740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cortical Gray-White Matter Blurring and Cognitive Morbidity in Focal Cortical Dysplasia.
    Blackmon K; Kuzniecky R; Barr WB; Snuderl M; Doyle W; Devinsky O; Thesen T
    Cereb Cortex; 2015 Sep; 25(9):2854-62. PubMed ID: 24770710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subclinical MRI disease activity influences cognitive performance in MS patients.
    Damasceno A; Damasceno BP; Cendes F
    Mult Scler Relat Disord; 2015 Mar; 4(2):137-43. PubMed ID: 25787189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of immunoablation and autologous hematopoietic stem cell transplantation on gray and white matter atrophy in multiple sclerosis.
    Lee H; Nakamura K; Narayanan S; Brown R; Chen J; Atkins HL; Freedman MS; Arnold DL
    Mult Scler; 2018 Jul; 24(8):1055-1066. PubMed ID: 28617152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive reserve moderates the impact of subcortical gray matter atrophy on neuropsychological status in multiple sclerosis.
    Modica CM; Bergsland N; Dwyer MG; Ramasamy DP; Carl E; Zivadinov R; Benedict RH
    Mult Scler; 2016 Jan; 22(1):36-42. PubMed ID: 25921038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patients.
    Patti F; De Stefano M; Lavorgna L; Messina S; Chisari CG; Ippolito D; Lanzillo R; Vacchiano V; Realmuto S; Valentino P; Coniglio G; Buccafusca M; Paolicelli D; D'Ambrosio A; Montella P; Brescia Morra V; Savettieri G; Alfano B; Gallo A; Simone I; Viterbo R; Zappia M; Bonavita S; Tedeschi G
    PLoS One; 2015; 10(3):e0120754. PubMed ID: 25816303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative MRI to understand Alzheimer's disease pathophysiology.
    Bozzali M; Serra L; Cercignani M
    Curr Opin Neurol; 2016 Aug; 29(4):437-44. PubMed ID: 27228309
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gray matter damage in multiple sclerosis: Impact on clinical symptoms.
    van Munster CE; Jonkman LE; Weinstein HC; Uitdehaag BM; Geurts JJ
    Neuroscience; 2015 Sep; 303():446-61. PubMed ID: 26164500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What explains gray matter atrophy in long-standing multiple sclerosis?
    Steenwijk MD; Daams M; Pouwels PJ; Balk LJ; Tewarie PK; Killestein J; Uitdehaag BM; Geurts JJ; Barkhof F; Vrenken H
    Radiology; 2014 Sep; 272(3):832-42. PubMed ID: 24761837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.